Stephanie Prior explores the road to recovery
In December 2011, an article was published in the National Post (‘Breast-implant-safety fears spread worldwide on eve of French recall announcement’, by Kate Kelland and Daniel Flynn), which revealed that the French government proposes to pay for ten thousands of French women to have breast implants removed if they are found to be responsible for causing cancer. The government said that they would not pay for inserting new implants unless the patient can show that they had reconstructive surgery following a mastectomy.
This controversy hit the headlines at a time when breast implants are increasingly popular.
Apparently over 40,000 women in the UK have been warned that their brand of breast implants – poly implant prothese (or PIP, as the French silicone implants are referred to) were made using industrial mattress filling. In 2011, eight women with this type of implant developed cancer although the authorities have now dismissed a link. It would seem that the greatest fear is that these implants could be leaking. They have a higher rupture rate than normal implants, which is usually 1% to 2%. However, the PIP implants rate is 5% according to the French authorities. Cosmetic breast surgery is very popular. The first surgical procedure was carried out in 1962 in the UK and statistics show that approximately 10,000 women have breast implants in the UK each year.
The current PIP scare is not the first. In 1992, there was a silicone scare in the United States. The US government temporarily removed silicone implants from the market in 1992 because they caused patient complications. Silicone-gel-filled implants are now available again in the USA. The US Food and Drug Association (FDA) approved silicone implants and they are safe to use if a doctor feels that you are a good candidate for them, although experts agree, however, that silicone implants are not right for all patients. Thereafter, many women in the UK simply opted for saline implants instead.
Trilucent implants
Then, in May 2000, apparently 5,000 women had received spya-oil-filled implants called Trilucent and these had to be removed due to concerns regarding toxicity. The Medical Devices Agency (MDA) was concerned about the long-term safety data in relation to the Trilucent breast implants and the concern was in relation to the breakdown of the lipid filler. Accordingly, samples from the explants and the retained implants apparently contained millimolar amounts of at least one type of aldehyde – a degradation product that would react with protein and DNA. All women who had these implants were advised to have them removed. This scare did not stop women wanting breast augmentation surgery and statistics show that between 2000 and 2007 the amount of women having implants went up by a massive 275%. There are, of course, lots of potential risks and side effects associated with this surgery, which can include: post-operative infection, chronic breast pain, breakage, necrosis of breast tissue, nipple numbness and leakage. Despite these risk factors, breast augmentation surgery is accordingly one of the most popular surgical procedures carried out today.
PIP implants
So, the controversial implants PIP have been linked by reports in France to the death of a woman from a rare form of cancer anaplastic large cell lymphoma (ALCL). It has been estimated that 300,000 women around the world have PIP implants. In its day, the company was once the world’s third largest producer of silicone implants, producing 100,000 per year and exporting 80% of its output. However, PIP itself was shut down and its product was banned last year, after it became apparent that the company was using non-authorised silicone gel that caused abnormally high rupture rates of these implants. More than 2,000 2 women have PIP.
In France about 523 women have had their implants removed and a further eight cases of cancer have been reported in patients with PUIP implants. Currently, it has been announced that the Welsh NHS are to pay to replace privately fitted PIP implants. Women in wales who have had PIP implants at private clinics can have them replaced for free on the NHS. To have the surgery, the women must prove that they have sought redress from their private care provider and they must be resident and registered with a GP in Wales.
In December 2011, French authorities recommended that 30,000 women have faulty breast implants removed as a precaution. Shockingly, Jean Claude Mas, the PIP breast implant boss, has been charged with causing bodily harm and has been placed under investigation on criminal charges. He is not being investigated on a more serious manslaughter charge over the 2010 cancer death of a French woman with PIP implants, but he will face a separate fraud trial over the manufacture of the implants, which is expected to begin in October 2012.
Apparently, Mr Mas had been using a homemade silicone gel concoction to cut costs. This gel had not been approved for medical use and included a mixture of agricultural and industrial grade silicone. The French authorities banned the PIP products nearly two years ago and French women that have been campaigning against PIP since then have welcomed Mr Mas’ arrest and investigation.
So what can be done?
I have received many enquiries from women who are concerned about their breast implants and I have recently met with two such women who have received treatment at the same hospital under the same surgeon. Both women are disappointed with the outcome of their surgery, both are in constant pain, and both would like the implants removed as soon as possible. In fact one of these women feels that her implants is leaking and the other women definitely knows that her implant is actually folded in half and thus causing a tight band across her chest and this leads to constant pain. This is not what she agreed to. Unfortunately, both of these women have been abandoned by their treating surgeon and the medical group who were initially happy to accept their money for payment of the surgery has been unwilling to provide them with any helpful advice. It would therefore seem that litigation is the only option.
Of course, if litigation is pursued the correct defendant will have to be identified and specific allegations of negligence will have to be included. Obviously each case will be different and some women will complain about the PIP implants and the fact that they should not have had these in the first place. Other women will be complaining because the breast augmentation surgery was not carried out to the standard of which they required.
The UK Association of Aesthetic Plastic Surgery KAAPS (http://ukaaps.org/
) has created a register for women who have had breast augmentation surgery to log their implants and surgeon on to its sister site, The Breast Implant Association
(http:www.breastimplantassociation.org).
This can easily help with early identification of any surgeon who has high complication rates and any implant with high problem rates so that the industry can be more proactive in resolving issues that arise.
Further, Facebook support groups have also been set out to assist women to discuss the issues that have arisen from the PIP announcement....read more
http://www.asdonline.co.uk/news/the-pip-breast-implant-controversy
In December 2011, an article was published in the National Post (‘Breast-implant-safety fears spread worldwide on eve of French recall announcement’, by Kate Kelland and Daniel Flynn), which revealed that the French government proposes to pay for ten thousands of French women to have breast implants removed if they are found to be responsible for causing cancer. The government said that they would not pay for inserting new implants unless the patient can show that they had reconstructive surgery following a mastectomy.
This controversy hit the headlines at a time when breast implants are increasingly popular.
Apparently over 40,000 women in the UK have been warned that their brand of breast implants – poly implant prothese (or PIP, as the French silicone implants are referred to) were made using industrial mattress filling. In 2011, eight women with this type of implant developed cancer although the authorities have now dismissed a link. It would seem that the greatest fear is that these implants could be leaking. They have a higher rupture rate than normal implants, which is usually 1% to 2%. However, the PIP implants rate is 5% according to the French authorities. Cosmetic breast surgery is very popular. The first surgical procedure was carried out in 1962 in the UK and statistics show that approximately 10,000 women have breast implants in the UK each year.
The current PIP scare is not the first. In 1992, there was a silicone scare in the United States. The US government temporarily removed silicone implants from the market in 1992 because they caused patient complications. Silicone-gel-filled implants are now available again in the USA. The US Food and Drug Association (FDA) approved silicone implants and they are safe to use if a doctor feels that you are a good candidate for them, although experts agree, however, that silicone implants are not right for all patients. Thereafter, many women in the UK simply opted for saline implants instead.
Trilucent implants
Then, in May 2000, apparently 5,000 women had received spya-oil-filled implants called Trilucent and these had to be removed due to concerns regarding toxicity. The Medical Devices Agency (MDA) was concerned about the long-term safety data in relation to the Trilucent breast implants and the concern was in relation to the breakdown of the lipid filler. Accordingly, samples from the explants and the retained implants apparently contained millimolar amounts of at least one type of aldehyde – a degradation product that would react with protein and DNA. All women who had these implants were advised to have them removed. This scare did not stop women wanting breast augmentation surgery and statistics show that between 2000 and 2007 the amount of women having implants went up by a massive 275%. There are, of course, lots of potential risks and side effects associated with this surgery, which can include: post-operative infection, chronic breast pain, breakage, necrosis of breast tissue, nipple numbness and leakage. Despite these risk factors, breast augmentation surgery is accordingly one of the most popular surgical procedures carried out today.
PIP implants
So, the controversial implants PIP have been linked by reports in France to the death of a woman from a rare form of cancer anaplastic large cell lymphoma (ALCL). It has been estimated that 300,000 women around the world have PIP implants. In its day, the company was once the world’s third largest producer of silicone implants, producing 100,000 per year and exporting 80% of its output. However, PIP itself was shut down and its product was banned last year, after it became apparent that the company was using non-authorised silicone gel that caused abnormally high rupture rates of these implants. More than 2,000 2 women have PIP.
In France about 523 women have had their implants removed and a further eight cases of cancer have been reported in patients with PUIP implants. Currently, it has been announced that the Welsh NHS are to pay to replace privately fitted PIP implants. Women in wales who have had PIP implants at private clinics can have them replaced for free on the NHS. To have the surgery, the women must prove that they have sought redress from their private care provider and they must be resident and registered with a GP in Wales.
In December 2011, French authorities recommended that 30,000 women have faulty breast implants removed as a precaution. Shockingly, Jean Claude Mas, the PIP breast implant boss, has been charged with causing bodily harm and has been placed under investigation on criminal charges. He is not being investigated on a more serious manslaughter charge over the 2010 cancer death of a French woman with PIP implants, but he will face a separate fraud trial over the manufacture of the implants, which is expected to begin in October 2012.
Apparently, Mr Mas had been using a homemade silicone gel concoction to cut costs. This gel had not been approved for medical use and included a mixture of agricultural and industrial grade silicone. The French authorities banned the PIP products nearly two years ago and French women that have been campaigning against PIP since then have welcomed Mr Mas’ arrest and investigation.
So what can be done?
I have received many enquiries from women who are concerned about their breast implants and I have recently met with two such women who have received treatment at the same hospital under the same surgeon. Both women are disappointed with the outcome of their surgery, both are in constant pain, and both would like the implants removed as soon as possible. In fact one of these women feels that her implants is leaking and the other women definitely knows that her implant is actually folded in half and thus causing a tight band across her chest and this leads to constant pain. This is not what she agreed to. Unfortunately, both of these women have been abandoned by their treating surgeon and the medical group who were initially happy to accept their money for payment of the surgery has been unwilling to provide them with any helpful advice. It would therefore seem that litigation is the only option.
Of course, if litigation is pursued the correct defendant will have to be identified and specific allegations of negligence will have to be included. Obviously each case will be different and some women will complain about the PIP implants and the fact that they should not have had these in the first place. Other women will be complaining because the breast augmentation surgery was not carried out to the standard of which they required.
The UK Association of Aesthetic Plastic Surgery KAAPS (http://ukaaps.org/
) has created a register for women who have had breast augmentation surgery to log their implants and surgeon on to its sister site, The Breast Implant Association
(http:www.breastimplantassociation.org).
This can easily help with early identification of any surgeon who has high complication rates and any implant with high problem rates so that the industry can be more proactive in resolving issues that arise.
Further, Facebook support groups have also been set out to assist women to discuss the issues that have arisen from the PIP announcement....read more
http://www.asdonline.co.uk/news/the-pip-breast-implant-controversy
